Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • How Immunosuppressants in Transplant Therapy cause Blood Vessel Damage
    How Immunosuppressants in Transplant Therapy cause Blood Vessel Damage
    1 April, 2026
    Understanding how immunosuppressants in transplant therapy cause blood vessel damage - C4d staining in liver tissue The study titled "Modeling antithymocyte globulin-induced microvasculopathy using human iPSC-derived vascularized liver organoids" aims to better understand the vascular side effects caused by antithymocyte globulin (ATG), a drug used in transplant medicine. Researchers created vascularized liver organoids from human [...]
  • Emerging Biomarkers in Kidney Disease
    Emerging Biomarkers in Kidney Disease
    18 March, 2026
    Chronic kidney disease (CKD) is a progressive condition affecting over 800 million individuals, accounting for roughly 13% of the global population (1). Over the past two decades, CKD has remained one of the leading causes of mortality. Due to its asymptomatic early stages, CKD is frequently diagnosed at advanced stages when severe complications have already [...]
  • World Kidney Day – March 12, 2026
    World Kidney Day - March 12, 2026
    11 March, 2026
    Approximately 1 in 10 people are affected by chronic kidney disease (CKD), impacting over 800 million individuals globally (1-3). CKD is a progressive condition where the kidneys gradually lose their ability to function properly. Early intervention is essential to preserving kidney health, slowing the progression of kidney disease and its complications, decreasing the risk of [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events